[
    [
        {
            "time": "",
            "orginal_text": "恒指收跌0.44%报26667.711点 汽车板块领跌",
            "features": {
                "keywords": [
                    "恒指",
                    "收跌",
                    "汽车板块",
                    "领跌"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融",
                    "汽车"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "恒指收跌0.44%报26667.711点 汽车板块领跌",
            "scores": {
                "News_content": "恒指收跌0.44%报26667.711点 汽车板块领跌",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "青蒿战役：欧美的计算、非洲的胜利以及印度的威胁",
            "features": {
                "keywords": [
                    "青蒿",
                    "欧美",
                    "非洲",
                    "印度",
                    "威胁"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "青蒿战役：欧美的计算、非洲的胜利以及印度的威胁",
            "scores": {
                "News_content": "青蒿战役：欧美的计算、非洲的胜利以及印度的威胁",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "orginal_text": "责令停售！复星医药子公司检出16.5万不合格药品 业务变化",
            "features": {
                "keywords": [
                    "复星医药",
                    "停售",
                    "不合格药品",
                    "业务变化"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "责令停售！复星医药子公司检出16.5万不合格药品 业务变化",
            "scores": {
                "News_content": "责令停售！复星医药子公司检出16.5万不合格药品 业务变化",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "举报门后又被爆出产品问题 复星药业召回大量注射剂 诉讼纠纷",
            "features": {
                "keywords": [
                    "复星药业",
                    "举报门",
                    "产品问题",
                    "召回",
                    "诉讼纠纷"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "举报门后又被爆出产品问题 复星药业召回大量注射剂 诉讼纠纷",
            "scores": {
                "News_content": "举报门后又被爆出产品问题 复星药业召回大量注射剂 诉讼纠纷",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "传统药企联姻创新药企再上演：云南白药3.5亿元基石投资中国抗体",
            "features": {
                "keywords": [
                    "传统药企",
                    "创新药企",
                    "云南白药",
                    "投资",
                    "中国抗体"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "传统药企联姻创新药企再上演：云南白药3.5亿元基石投资中国抗体",
            "scores": {
                "News_content": "传统药企联姻创新药企再上演：云南白药3.5亿元基石投资中国抗体",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "艾德证券期货：恒指上方压力较大，警惕联储降息后下跌",
            "features": {
                "keywords": [
                    "艾德证券期货",
                    "恒指",
                    "压力",
                    "联储降息",
                    "警惕"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "艾德证券期货：恒指上方压力较大，警惕联储降息后下跌",
            "scores": {
                "News_content": "艾德证券期货：恒指上方压力较大，警惕联储降息后下跌",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "复星医药业绩增速遇阻 子公司药品不合格敲警钟",
            "features": {
                "keywords": [
                    "复星医药",
                    "业绩增速",
                    "遇阻",
                    "子公司",
                    "药品不合格",
                    "警钟"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "复星医药业绩增速遇阻 子公司药品不合格敲警钟",
            "scores": {
                "News_content": "复星医药业绩增速遇阻 子公司药品不合格敲警钟",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]